You are here

Achillion to Present at the SVB Leerink 8th Annual Global Healthcare Conference

NEW HAVEN, Conn., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients and families affected by complement-mediated diseases, today announced that Joseph Truitt, President and Chief Executive Officer of Achillion, will present at the SVB Leerink 8th Annual Global Healthcare Conference on Thursday, February 28, 2019, at 2PM ET at the Lotte New York Palace, New York, NY.
Tuesday, February 19, 2019 - 06:00